Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Mechanism-Based Inhibitory and PPARα-Dependent Modulating Effects of Silybin on Principle Hepatic Drug-Metabolizing Enzymes

Hong Wang, Tingting Yan, Yuan Xie, Min Zhao, Yuan Che, Jun Zhang, Huiying Liu, Lijuan Cao, Xuefang Cheng, Yang Xie, Feiyan Li, Qu Qi, Guangji Wang and Haiping Hao
Drug Metabolism and Disposition January 13, 2015, dmd.114.061622; DOI: https://doi.org/10.1124/dmd.114.061622
Hong Wang
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tingting Yan
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuan Xie
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Zhao
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuan Che
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Zhang
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huiying Liu
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijuan Cao
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuefang Cheng
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Xie
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feiyan Li
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qu Qi
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guangji Wang
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haiping Hao
China Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hhp_770505@hotmail.com

Data Supplement

Files in this Data Supplement:

  • Supplemental Data -

    Supplemental Table 1 - List of primer sequences used for RT-PCR

    Supplemental Figure 1 - Effects of co-administration of silybin and fenofibrate on the mRNA levels of UGTs in HepG2 cells

    Supplemental Figure 2 - mRNA levels of Ugt isozymes in the livers of mice treated with silybin and/or fenofibrate

    Supplemental Figure 3 - Activities of Ugt isozymes in the livers of mice treated with silybin and/or fenofibrate

    Supplemental Figure 4 - Activities of main P450s in the livers of mice treated with silybin for only once

  View article

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics